On AI and computational support of biochemistry, with Alan Roth

AI’s growing influence in pharma is transforming traditional drug discovery timelines.

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Alan Roth, CEO of Oxford Drug Design, about the use of AI to accelerate discovery of new treatments for cancer, infectious diseases, and cystic fibrosis.

Roth discusses combining deep enzyme biology expertise with GenAI and targeting leucyl-tRNA synthetase.

You can listen to episode 231 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.